- Concert Pharma (NASDAQ:CNCE): Q3 GAAP EPS of -$0.72 beats by $0.11.
- Revenue of $0.01M (flat Y/Y)
- Press Release
Concert Pharma EPS beats by $0.11
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CNCE | - | - |
Concert Pharmaceuticals, Inc. |